carnitine has been researched along with Bowel Diseases, Inflammatory in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, SA | 1 |
| Ogawa, SA | 1 |
| Chau, L | 1 |
| Whelan, KA | 1 |
| Hamilton, KE | 1 |
| Chen, J | 1 |
| Tan, L | 1 |
| Chen, EZ | 1 |
| Keilbaugh, S | 1 |
| Fogt, F | 1 |
| Bewtra, M | 1 |
| Braun, J | 1 |
| Xavier, RJ | 1 |
| Clish, CB | 1 |
| Slaff, B | 1 |
| Weljie, AM | 1 |
| Bushman, FD | 1 |
| Lewis, JD | 1 |
| Li, H | 1 |
| Master, SR | 1 |
| Bennett, MJ | 1 |
| Nakagawa, H | 1 |
| Wu, GD | 1 |
| Pochini, L | 1 |
| Scalise, M | 1 |
| Galluccio, M | 1 |
| Indiveri, C | 1 |
| Shimizu, T | 1 |
| Kijima, A | 1 |
| Masuo, Y | 1 |
| Ishimoto, T | 1 |
| Sugiura, T | 1 |
| Takahashi, S | 1 |
| Nakamichi, N | 1 |
| Kato, Y | 1 |
| Danese, C | 1 |
| Cirene, M | 1 |
| Colotto, M | 1 |
| Aratari, A | 1 |
| Amato, S | 1 |
| Di Bona, S | 1 |
| Curione, M | 1 |
| Merra, G | 1 |
| Gasbarrini, G | 1 |
| Laterza, L | 1 |
| Pizzoferrato, M | 1 |
| Poscia, A | 1 |
| Scaldaferri, F | 1 |
| Arena, V | 1 |
| Fiore, F | 1 |
| Cittadini, A | 1 |
| Sgambato, A | 1 |
| Franceschi, F | 1 |
| Gasbarrini, A | 1 |
| Hayashi, M | 1 |
| Tomita, M | 1 |
| Schmidt-Sommerfeld, E | 1 |
| Penn, D | 1 |
| Bieber, LL | 1 |
| Kerner, J | 1 |
| Rossi, TM | 1 |
| Lebenthal, E | 1 |
2 reviews available for carnitine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
OCTN cation transporters in health and disease: role as drug targets and assay development.
Topics: Acetylcholine; Alzheimer Disease; Amino Acid Sequence; Animals; Biological Transport; Carnitine; Hum | 2013 |
Mechanistic analysis for drug permeation through intestinal membrane.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bacterial Infections; Caco-2 Cells | 2007 |
5 other studies available for carnitine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitines.
Topics: Animals; Caco-2 Cells; Carnitine; Citrobacter rodentium; Enterobacteriaceae Infections; Female; Huma | 2021 |
Gene ablation of carnitine/organic cation transporter 1 reduces gastrointestinal absorption of 5-aminosalicylate in mice.
Topics: Animals; Biological Availability; Biological Transport, Active; Carnitine; HEK293 Cells; Humans; Inf | 2015 |
Cardiac involvement in inflammatory bowel disease: role of acylcarnitine esters.
Topics: Adult; Cardiomyopathy, Dilated; Carnitine; Case-Control Studies; Female; Heart Ventricles; Humans; I | 2011 |
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Female; Humans; Inflammatory Bowel | 2012 |
Carnitine ester excretion in pediatric patients receiving parenteral nutrition.
Topics: Absorption; Adolescent; Adult; Carnitine; Child; Child, Preschool; Esters; Gastrointestinal Diseases | 1990 |